ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 14 filers reported holding ZEALAND PHARMA A S in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | 0.0% | 23 | -25.8% | 0.00% | – |
| Q1 2020 | $1,000 | – | 31 | +416.7% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 6 | -84.6% | 0.00% | – |
| Q3 2019 | $1,000 | -96.8% | 39 | -97.3% | 0.00% | -100.0% |
| Q2 2019 | $31,000 | -24.4% | 1,445 | -40.7% | 0.00% | 0.0% |
| Q1 2019 | $41,000 | +36.7% | 2,435 | -6.9% | 0.00% | 0.0% |
| Q4 2018 | $30,000 | +76.5% | 2,616 | +151.5% | 0.00% | +100.0% |
| Q3 2018 | $17,000 | +183.3% | 1,040 | +105.1% | 0.00% | – |
| Q2 2018 | $6,000 | -68.4% | 507 | -60.7% | 0.00% | -100.0% |
| Q1 2018 | $19,000 | – | 1,291 | – | 0.00% | – |
| Q4 2017 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 48,957 | $631,000 | 0.10% |
| GOLDMAN SACHS GROUP INC | 500,916 | $6,517,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 220,523 | $2,869,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| US BANCORP \DE\ | 509 | $7,000 | 0.00% |
| CREDIT SUISSE AG/ | 285 | $4,000 | 0.00% |
| MORGAN STANLEY | 6,705 | $87,000 | 0.00% |
| UBS Group AG | 351 | $4,000 | 0.00% |
| JANE STREET GROUP, LLC | 23,976 | $312,000 | 0.00% |